Pacific biosciences of california stock.
Pacific Biosciences of California Inc’s price is currently up 27.53% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $11.79 and a low of $8.01. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.
April 11, 2023 at 12:00 PM · 4 min read. Pacific Biosciences of California (PACB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in ...٢٧/٠١/٢٠٢٣ ... The common stock is listed on the Nasdaq Global Select Market under the symbol “PACB”. Based in Menlo Park, California, Pacific Biosciences ...Pacific Biosciences of California Inc’s Stock Price as of Market Close As of November 14, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $7.22. Pacific Biosciences of California Inc is up 12.11% from its previous closing price of $6.44.Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Fourth Quarter and the Fiscal Year Ended December 31, 2021 Jan 12 Price target …The stock of Pacific Biosciences of California (PACB 2.27%), a company developing DNA sequencing machines, is losing ground after an investor update. Preliminary fourth-quarter sales figures ...
٠٧/٠٨/٢٠٢٣ ... 9/13/2023 Pacific Biosciences CA sees its Relative Strength Rating reach the... Pacific Biosciences of California Stock Clears Key Benchmark, ...
Apr 21, 2023 · Valuation for Pacific Biosciences In 2023, the firm anticipates generating revenues in the range of $165 million to $180 million, reflecting a 29% to 40% increase. During the fourth quarter, 76 ... Stock Quote. Price Change Change(%) Volume 52 Week High 52 Week Low ... Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025 [email protected].
PACB Stock Summary and Trading Ideas (Pacific Biosciences Of California | NASDAQ:PACB) · Trade Ideas for Best Option Strategies for PACB by Theoretical Edge and ...Pacific Biosciences of California's CEO is Christian O. Henry, appointed in Sep 2020, has a tenure of 3.17 years. total yearly compensation is $6.62M, comprised of 10.1% salary and 89.9% bonuses, including company stock and options. directly owns 0.088% of the company’s shares, worth $2.03M.Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on August 02,2023. Pacific Biosciences (PACB) delivered earnings and revenue ...S&P 500 U.S. 10 Yr Barron's 400 Market Data Stocks PACB Overview Pacific Biosciences of California Inc. U.S.: Nasdaq About Pacific Biosciences of California …PacBio announced record first-quarter revenue of $29 million, an 86% year-over-year increase and exactly what analysts expected. Meanwhile, the company recorded a net loss of $87.4 million -- or a ...
This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled ...
Nov 14, 2023 · Pacific Biosciences of California Inc’s Stock Price as of Market Close As of November 14, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $7.22. Pacific Biosciences of California Inc is up 12.11% from its previous closing price of $6.44.
Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis. Pacific Biosciences of California last issued its quarterly earnings results on October 30th, 2023. The biotechnology company reported ($0.27) earnings per share for the quarter, beating analysts' consensus estimates of ($0.29) by $0.02. The business earned $55.70 million during the quarter, compared to analyst estimates of $48.76 million.PacBio Also Closes $300 Million PIPE Financing in Support of Transaction. MENLO PARK, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read sequencing platforms, and Omniome, a San Diego-based …As of Tuesday, October 31, Pacific Biosciences of California Inc’s PACB share price has dipped by 13.08%, which has investors questioning if this is right time to buy. Premium Products ... Stock Superstars Report Get stock ideas inspired by the market's leading professionals; VMQ Stocks For the ...Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, ... Pacific Biosciences of California Inc (NASDAQ:PACB) 8.89. Delayed Data. As of Dec 01As of February 15, 2023, 4:00 PM CST, Pacific Biosciences of California Inc’s stock price was $11.09. Pacific Biosciences of California Inc is up 7.88% from its previous closing price of $10.28. During the last market session, Pacific Biosciences of California Inc’s stock traded between $9.75 and $10.47.
A steep rise in short interest was recorded in Pacific Biosciences of California Inc stocks on Oct 30, 2023, growing by 2.05 million shares to a total of 35.12 million shares. Yahoo Finance data shows the prior-month short interest on Sep 28, 2023 was 33.07 million shares. There was a rise of 5.84%, which implies that there is a …Apr 11, 2023 · Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on August 02,2023. Pacific Biosciences (PACB) delivered earnings and revenue ... PacBio highly accurate long-read sequencing provides the most comprehensive view of genomes, transcriptomes, and epigenomes. Learn how SMRT sequencing powers genomic insights in humans, plants, animals and microbes.Pacific Biosciences of California's CEO is Christian O. Henry, appointed in Sep 2020, has a tenure of 3.17 years. total yearly compensation is $6.62M, comprised of 10.1% salary and 89.9% bonuses, including company stock and options. directly owns 0.088% of the company’s shares, worth $2.03M.٢٥/٠٩/٢٠٢٣ ... Why Pacific Biosciences of California Inc's (PACB) Stock Is Down 5.37% ... Avoid the stress of overpaying for a stock or missing an opportunity by ...24 Jan, 2023, 23:18 ET. MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously ...Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. ... Stock Pacific Biosciences of California, Inc. - Nasdaq News. PacBio Announces …
In other news concerning Pacific Biosciences of California, insider Michele Farmer sold 5,165 shares of the company’s stock on May 18th at an average price of $12.59 per share, resulting in a total transaction value of $65,027.35. Following this sale, Farmer now holds 107,577 shares of PACB stock with an approximate value of $1,354,394.43.
Source: Shutterstock. We wouldn't blame Pacific Biosciences of California, Inc. NASDAQ:PACB) shareholders if they were a little worried about the fact that Christian O. Henry, the President recently netted about US$980k selling shares at an average price of US$10.12. That sale reduced their total holding by 29% which is hardly …Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. ... Stock Pacific Biosciences of California, Inc. - Nasdaq . News Pacific Biosciences of California, Inc ...9.38M. AMZN. 146.74. +0.02%. 21.61M. View today's Pacific Biosciences of California stock price and latest PACB news and analysis. Create real-time notifications to follow any changes in the live ...Nov 17, 2023 · Pacific Biosciences of California Inc’s Stock Price as of Market Close As of November 17, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $8.40. Pacific Biosciences of California Inc is up 10.67% from its previous closing price of $7.59. Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. ... Stock Pacific Biosciences of California, Inc. - Nasdaq . News Pacific Biosciences of …Pacific Biosciences of California (PACB): Stock Market Performance, Earnings Growth, and Market Analysis. On June 30, 2023, Pacific Biosciences of California (PACB) had a mixed performance in the stock market. The stock opened at $13.77 and fluctuated between $13.59 and $14.07 throughout the day. The trading …Get the latest PACB stock quote, news, history and other vital information to help you with your stock trading and investing. See the performance outlook, earnings date, dividend …SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger agreement, previously announced on November 1, 2018, under which Illumina would acquire Pacific Biosciences at a fully diluted enterprise value of approximately $1.2 billion in an all ...A high-level overview of Pacific Biosciences of California, Inc. (PACB) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
According to 6 analyst offering 12-month price targets in the last 3 months, Pacific Biosciences has an average price target of $14.67 with a high of $17.00 and a low of $12.00. Below is a summary ...
Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis.
See Pacific Biosciences of California, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.٠٣/٠٤/٢٠٢١ ... Pacbio (Pacific Biosciences of California Inc) (Stock: PACB) CEO Christian Henry Interview on Business Outlook and Growth.Pacific Biosciences of California has been profitable 1 over the past 10 years. Over the past twelve months, the company had a revenue of $146.10 million and Loss Per Share of $1.35.One such stock that merits attention is Pacific Biosciences of California Inc ( NASDAQ:PACB ). The stock, which is currently priced at 10.06, recorded a loss of 3.5% in a day and a 3-month ...Stocks of Pacific Biosciences of California Inc saw a sharp rise in short interest on Nov 14, 2023 jumping by 1.49 million shares to 39.23 million. Data from Yahoo Finance shows that the short interest on Oct 12, 2023 was 37.74 million shares. A jump of 3.8% in short interest reflects a negative sentiment towards the stock.٢١/٠٩/٢٠٢٣ ... In fact, the recent sale by Christian O. Henry was the biggest sale of Pacific Biosciences of California shares made by an insider individual in ...Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 …Nov 15, 2023 · Pacific Biosciences of California Inc is up 8.17% from its previous closing price of $7.22. During the last market session, Pacific Biosciences of California Inc’s stock traded between $7.00 and $7.43. Currently, there are 255.00 million shares of Pacific Biosciences of California Inc stock available for purchase. RIP to These 3 Dying Medical Stocks. PACB – Since the high inflation is leading to rising healthcare spending, it could be wise to sell fundamentally weak medical stocks, Pacific Biosciences (PACB), DermTech (DMTK), and Genetic Technologies (GENE), before things get even uglier. Continue reading…. While investors anticipate the …١٢/١٠/٢٠٢٣ ... Shares of Pacific Biosciences of California (PACB) - Get Free Report, a life science technology company focused on solving genetic problems, ...If you live in California, chances are you get your electricity and gas services from Pacific Gas and Electric Company (PG&E). As a PG&E customer, you receive a monthly bill for your energy usage.
Track Pacific Biosciences of California Inc (PACB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Jan 11, 2022 · The stock of Pacific Biosciences of California (PACB 2.27%), a company developing DNA sequencing machines, is losing ground after an investor update. Preliminary fourth-quarter sales figures ... Dec 4, 2023 · Ulysses Erickson. December 4, 2023. Company. Pacific Biosciences of California Inc (NASDAQ:PACB) has a beta value of 1.83 and has seen 0.81 million shares traded in the recent trading session. The company, currently valued at $2.37B, closed the recent trade at $8.86 per share which meant it lost -$0.02 on the day or -0.17% during that session. Pacific Biosciences of California, Inc. (PACB) latest earnings report: revenue, EPS, surprise, history, news and analysis.Instagram:https://instagram. nexstar media group stockretailmenot athletabest stocks to buy now fintechzoombank apps all Jan 11, 2022 · The stock of Pacific Biosciences of California (PACB 2.27%), a company developing DNA sequencing machines, is losing ground after an investor update. Preliminary fourth-quarter sales figures ... During the last session, Pacific Biosciences of California Inc (NASDAQ:PACB)’s traded shares were 3.39 million, with the beta value of the company hitting 1.79. At the end of the trading day, the stock’s price was $8.48, reflecting an intraday loss of -3.53% or -$0.31. The 52-week high for the ... new energy stockssusan b anthony coin worth Apr 30, 2021 · PacBio announced record first-quarter revenue of $29 million, an 86% year-over-year increase and exactly what analysts expected. Meanwhile, the company recorded a net loss of $87.4 million -- or a ... Nov 14, 2023 · Pacific Biosciences of California Inc’s Stock Price as of Market Close As of November 14, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $7.22. Pacific Biosciences of California Inc is up 12.11% from its previous closing price of $6.44. investment opportunities for non accredited investors Pacific Biosciences of California, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.3. Operator: Good afternoon, everyone, and welcome to the PacBio Third Quarter ...Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis.